Remove Healthcare Remove Manufacturing Remove Privacy
article thumbnail

FAIR Data Principles in Life Sciences: A case for Data Intelligence Cloud

Collibra

By adopting FAIR Data Principles, life sciences firms (pharmaceuticals, biotech, medical device manufacturers) can accelerate data sharing, improve data literacy (understanding of data) and increase overall transparency and auditability when working with data. Address data quality and privacy issues at scale to ensure data integrity.

Cloud 97
article thumbnail

CVS Sued for Alleged Privacy Violations

Hunton Privacy

The letters encouraged the physicians to prescribe drugs made by pharmaceutical manufacturers, who paid CVS to send them. This purported disclosure of PHI would violate the HIPAA Privacy Rule’s prohibitions against disclosing PHI for marketing purposes without an individual’s authorization. In 2009, CVS paid $2.25

Privacy 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Supreme Court Strikes Down Vermont Prescriber Privacy Law

Hunton Privacy

The law also mandates that “[p]harmaceutical manufacturers and pharmaceutical marketers shall not use prescriber-identifiable information for marketing or promoting a prescription drug unless the prescriber consents.”. Read our previous coverage of the IMS Health case.

Privacy 40
article thumbnail

Customer Experience Trends: How To Stand Out From the Crowd

Reltio

Every organization — from mom and pop shops to pharmaceutical manufacturers — must adopt tools and techniques for providing the hyper-personalized experiences customers require at every touchpoint in their journey. . Your Customer Experience Is Your Most Valuable Asset. A customer data strategy is no longer optional.

article thumbnail

House of Representatives Passes Bill to Permit Broader Use and Disclosure of Protected Health Information for Research Purposes

Hunton Privacy

Currently, the HIPAA Privacy Rule permits the use and disclosure of PHI for research purposes without requiring authorization from an individual but does require that any waiver of the authorization requirement be approved by an institutional review board or a privacy board.

article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

This is the sixth installment in Hogan Lovells’ series on the California Consumer Privacy Act. The California Consumer Privacy Act of 2018 (CCPA) adds another set of privacy requirements for health and life sciences companies. Some considerations in making that assessment: Is the company a provider of health care?

Privacy 45
article thumbnail

Security in a World of Physically Capable Computers

Schneier on Security

This fails in low-cost devices , whose manufacturers don't have security teams to write the patches: if you want to update your DVR or webcam for security reasons, you have to throw your old one away and buy a new one. The courts have traditionally not held software manufacturers liable for vulnerabilities.

Security 100